Cyberonics NCP Patient Adverse Events To Be Reviewed In Meeting With FDA

Cyberonics plans to meet with FDA to review adverse event data for certain patients who received its implantable NCP NeuroCybernetic Prosthesis vagus nerve stimulation system for epilepsy, including 83 deaths and 116 infections reported to the agency.